In SOD1 mutants, mTOR inhibition worsens ALS, while similar mTOR inhibition in elevated TDP-43 levels protects against neuronal degeneration [41,42,43,44,45,46] despite the pathogenesis of ALS being associated with TDP-43 [47,48,49]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.